Malaysia-Indonesia Biopartnering Initiative
Biomedical Advancement in Southeast Asia
Pioneer and Leader in Clinically Accredited Pharmacogenomics Testing
Precision Diagnostics, a Pioneer and Leader in Clinically Accredited Pharmacogenomics Testing, was honored to participate in the Malaysia-Indonesia Biopartnering Initiative, held from 29th to 30th April 2025 at Oakwood Suites, Jakarta. This event brought together key stakeholders in healthcare, bioceuticals, and sustainable innovation sectors from both nations, paving the way for cross-border partnerships that redefine biomedical advancement in Southeast Asia.
Representing Precision Diagnostics, Dr. Gew (Chief Operating Officer) and Maria Sue Chieng Phang (Operations Director) actively engaged with industry leaders, participated in meaningful exchanges, and seized valuable networking opportunities during the Healthcare Business Forum. It was an honor to meet YBrs. Mohd Khairul Fidzal Abdul Razak, Chief Executive Officer of the Malaysian Bioeconomy Development Corporation.
During the event, PartnerSehat facilitated introductions between our representatives and Jeffri Ardiyanto, M.App.Sc (Director of Pharmaceutical Resilience and Medical Devices) and Lupi Trilaksono (Director for the Center of Health Resources Policy System) from Indonesia’s Ministry of Health. Discussions centred on PRECISE Pharmacogenomics’s market potential and clinical value in Indonesia’s healthcare landscape. PRECISE Pharmacogenomics has already achieved successful integration in Malaysia and demonstrates tremendous potential to empower Indonesia’s precision healthcare.
Inspired by Dr. Gew, PRECISE Pharmacogenomics is a 𝗟𝗜𝗙𝗘-𝗦𝗔𝗩𝗜𝗡𝗚 genetic test that emphasizes lifetime prevention, plays a critical role in modern healthcare, and sets a new standard for pre-emptive medication. Indonesia’s healthcare landscape stands to benefit significantly from this framework, particularly in advancing personalized medicine and precision healthcare through collaboration.
Malaysia-Indonesia Biopartnering Initiative
Precision Diagnostics is proud to contribute to a regional movement driving innovation in pharmacogenomics, regulatory excellence, and sustainable bio-based solutions, reinforcing our commitment to clinically impactful diagnostics and precision healthcare.
Recent Events
